2 - Management of the Axilla - Past, Present & Future

Saturday, April 4, 2020

9:00 AM – 9:45 AM

Location: Forum General

1) Artificial Intelligence: The Word Soup
a) AI vs DL vs ML
b) Building blocks of an AI algorithm
2) AI in Breast Imaging
a) Detection vs other tasks
b) Future of AI in Breast Imaging
3) Human vs AI
a) Pitfalls and benefits
b) How AI can be your friend

Learning Objectives:

1. Describe the rationale behind axillary lymph node biopsy prior to neoadjuvant systemic therapy.
2. List the optimal imaging modalities for identifying pathologically involved axillary lymph nodes.
3. Define the characteristics of patients who can safely avoid completion axillary dissection.

Speaker(s)

Beth Overmoyer, MD

Director, Inflammatory Breast Cancer Program
Dana Farber Cancer Institute,
Harvard Medical School

Disclosure: Disclosure information not submitted.

Panelist(s)

Jennifer Gass, MD, FACS

Co-Director
Breast Health Center/ Women and Infants Hospital/Care New England
Brown Universtiy

Disclosure: Disclosure information not submitted.
Jordana Phillips, MD

Assistant Professor of Radiology
Beth Israel Deaconess Medical Center
Harvard Medical School

Disclosure: Disclosure information not submitted.
Julia White, MD

Professor and Vice Chair
The Ohio State University James Cancer Hospital
The Ohio State University

Disclosure: Disclosure information not submitted.